Algert Global LLC Grows Stock Position in Owens & Minor, Inc. (NYSE:OMI)

Algert Global LLC increased its stake in shares of Owens & Minor, Inc. (NYSE:OMIFree Report) by 189.4% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 276,438 shares of the company’s stock after purchasing an additional 180,922 shares during the quarter. Algert Global LLC owned 0.36% of Owens & Minor worth $4,337,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of OMI. Vanguard Group Inc. boosted its holdings in shares of Owens & Minor by 1.9% in the first quarter. Vanguard Group Inc. now owns 8,749,866 shares of the company’s stock valued at $242,459,000 after acquiring an additional 162,182 shares in the last quarter. Royce & Associates LP raised its stake in shares of Owens & Minor by 179.4% during the 3rd quarter. Royce & Associates LP now owns 80,914 shares of the company’s stock worth $1,270,000 after buying an additional 51,955 shares in the last quarter. Deerfield Management Company L.P. Series C boosted its stake in shares of Owens & Minor by 30.6% in the second quarter. Deerfield Management Company L.P. Series C now owns 6,371,440 shares of the company’s stock valued at $86,014,000 after buying an additional 1,493,852 shares in the last quarter. Renaissance Technologies LLC grew its holdings in Owens & Minor by 16.5% during the second quarter. Renaissance Technologies LLC now owns 1,246,600 shares of the company’s stock worth $16,829,000 after acquiring an additional 176,250 shares during the period. Finally, Dimensional Fund Advisors LP lifted its holdings in Owens & Minor by 1.7% in the second quarter. Dimensional Fund Advisors LP now owns 4,534,204 shares of the company’s stock valued at $61,213,000 after acquiring an additional 76,599 shares during the period. 98.04% of the stock is currently owned by hedge funds and other institutional investors.

Owens & Minor Stock Performance

Shares of NYSE:OMI opened at $12.35 on Monday. Owens & Minor, Inc. has a one year low of $11.42 and a one year high of $28.35. The business’s fifty day moving average price is $13.75 and its two-hundred day moving average price is $15.16. The company has a current ratio of 1.09, a quick ratio of 0.45 and a debt-to-equity ratio of 2.11.

Owens & Minor (NYSE:OMIGet Free Report) last posted its quarterly earnings data on Monday, November 4th. The company reported $0.42 EPS for the quarter, topping analysts’ consensus estimates of $0.41 by $0.01. Owens & Minor had a positive return on equity of 14.60% and a negative net margin of 0.46%. The firm had revenue of $2.72 billion during the quarter, compared to analysts’ expectations of $2.68 billion. During the same quarter last year, the business posted $0.44 EPS. The firm’s quarterly revenue was up 5.0% compared to the same quarter last year. Sell-side analysts forecast that Owens & Minor, Inc. will post 1.49 EPS for the current fiscal year.

Wall Street Analyst Weigh In

OMI has been the subject of a number of research analyst reports. Barclays cut their price target on shares of Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating for the company in a report on Tuesday, November 5th. UBS Group reduced their price target on shares of Owens & Minor from $28.00 to $25.00 and set a “buy” rating for the company in a research report on Tuesday, November 5th. JPMorgan Chase & Co. lowered their price target on Owens & Minor from $22.00 to $18.00 and set an “underweight” rating on the stock in a report on Wednesday, August 21st. Citigroup dropped their price objective on Owens & Minor from $21.00 to $18.50 and set a “buy” rating for the company in a research note on Tuesday, November 5th. Finally, StockNews.com downgraded Owens & Minor from a “buy” rating to a “hold” rating in a research report on Monday, August 26th. Two analysts have rated the stock with a sell rating, five have given a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $18.50.

View Our Latest Analysis on Owens & Minor

Owens & Minor Profile

(Free Report)

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.

See Also

Institutional Ownership by Quarter for Owens & Minor (NYSE:OMI)

Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.